cryoprecipitate การใช้

• Ratnoff also favored using cryoprecipitate from local donors to treat these patients.
• There's only a tiny market for cryoprecipitate, a clotting factor.
• Cryoprecipitate can be made from other plasma components.
• Prothrombin complex concentrate, cryoprecipitate and fresh frozen plasma are commonly used coagulation factor products.
• Instead of using cryoprecipitate, he uses two other commercially prepared substances : collagen, a protein found in connective tissue, and fibrin, a blood protein that aids clotting.
• Initial treatment involves supportive management with intravenous fluids, intravenous glucose and blood products, including fresh frozen plasma and cryoprecipitate to correct DIC . The foetus should be monitored with cardiotocography.
• In 1974 Dr . Judith Graham Pool ( Who previously discovered Cryoprecipitate, a safer treatment ), described the products as " dangerous ", " unethical " and warned against their use.
• In patients with fibrinogen deficiency, the correction of bleeding is possible by infusion of fresh frozen plasma ( FFP ), cryoprecipitate ( a fibrinogen-rich plasma fraction ) or by fibrinogen concentrates.
• To seal the membranes, they use the woman's own blood platelets, the cell-like particles that help form clots, and a substance called cryoprecipitate, also made from her blood.
• The patient was hospitalized and successfully treated with fresh frozen plasma, cryoprecipitate and vitamin K . In conclusion, paradoxical thrombosis and hemorrhage should raise the suspicion for superwarfarin toxicity in the appropriate clinical setting.
• Improved blood-clotting medicine called cryoprecipitate, introduced in the early 1970s, was intended to prolong and enrich the lives of the 20, 000 Americans with hemophilia, a genetic disorder that affects mostly men.
• Cryoprecipitate, and later in 1970, lyophilized factor VIII concentrates became available for the treatment of hemophilia A . One of the most frustrating complications in the treatment of hemophilia then, was the development of inhibitors to Factor VIII or Factor IX, which neutralized the activity of the factor given for treatment.
• A total of 1 IU / kg of protein C concentrate or 1 mL / kg of fresh frozen plasma will increase the plasma concentration of protein C by 1 IU / dL . Cases with comorbid pathological bleeding may require additional transfusions with platelet concentrate ( 10 15 mL / kg ) or cryoprecipitate ( 5 mL / kg ).